AVAH vs. PNTG, TLMD, VMD, APR, ADUS, BTSG, AHCO, EHAB, CHE, and OPCH
Should you be buying Aveanna Healthcare stock or one of its competitors? The main competitors of Aveanna Healthcare include The Pennant Group (PNTG), SOC Telemed (TLMD), Viemed Healthcare (VMD), Apria (APR), Addus HomeCare (ADUS), BrightSpring Health Services (BTSG), AdaptHealth (AHCO), Enhabit (EHAB), Chemed (CHE), and Option Care Health (OPCH). These companies are all part of the "medical" sector.
Aveanna Healthcare (NASDAQ:AVAH) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, community ranking, valuation and earnings.
Aveanna Healthcare has a beta of 2.07, meaning that its share price is 107% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 2.01, meaning that its share price is 101% more volatile than the S&P 500.
In the previous week, The Pennant Group had 1 more articles in the media than Aveanna Healthcare. MarketBeat recorded 8 mentions for The Pennant Group and 7 mentions for Aveanna Healthcare. The Pennant Group's average media sentiment score of 0.68 beat Aveanna Healthcare's score of 0.44 indicating that The Pennant Group is being referred to more favorably in the news media.
The Pennant Group has lower revenue, but higher earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.
The Pennant Group has a net margin of 2.86% compared to Aveanna Healthcare's net margin of -5.92%. The Pennant Group's return on equity of 13.42% beat Aveanna Healthcare's return on equity.
88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 7.8% of Aveanna Healthcare shares are held by insiders. Comparatively, 5.8% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Aveanna Healthcare currently has a consensus target price of $1.83, suggesting a potential downside of 58.24%. The Pennant Group has a consensus target price of $25.25, suggesting a potential downside of 13.85%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts clearly believe The Pennant Group is more favorable than Aveanna Healthcare.
The Pennant Group received 11 more outperform votes than Aveanna Healthcare when rated by MarketBeat users. Likewise, 44.87% of users gave The Pennant Group an outperform vote while only 38.71% of users gave Aveanna Healthcare an outperform vote.
Summary
The Pennant Group beats Aveanna Healthcare on 14 of the 18 factors compared between the two stocks.
Get Aveanna Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aveanna Healthcare Competitors List
Related Companies and Tools
Free AVAH Stock Alerts